Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey

Brain

Volumn 123, Issue 6, 2000, Pages 1102-1111

  Broadley, S A ^a   Deans, J ^a   Sawcer, S J ^a   Clayton, D ^b   Compston, D Alastair S ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c E D Adrian Building ^*  (United Kingdom)

Author keywords

Autoimmune disease; Epidemiology; Familial; Multiple sclerosis; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FEMALE; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0034023587     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.6.1102     Document Type: Article

References (58)

1. Alter M, Sawyer GT, Latham K. The frequency of diabetes mellitus in families of patients with multiple sclerosis. Neurology 1970; 20: 619-21.
2. Baker HW, Balla JI, Burger HG, Ebeling P, Mackay IR. Multiple sclerosis and autoimmune diseases. Aust NZ J Med 1972; 2: 256-60.
3. Barker JN. Psoriasis as a T cell-mediated autoimmune disease. [Review]. Hosp Med 1998; 59: 530-3.
4. Becker KG, Simon RM, Bailey-Wilson JE, Freidlin B, Biddison WE, McFarland HF, et al. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998; 95: 9979-84.
5. Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med 1994; 96: 457-62.
6. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149: 916-24.
7. Bias WB, Reveille JD, Beaty TH, Meyers DA, Arnett FC. Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet 1986; 39: 584-602.
8. Brandrup F, Green A. The prevalence of psoriasis in Denmark. Acta Derm Venereol 1981; 61: 344-6.
9. Coles A, Wing M, Smith S, Corradu F, Greer S, Taylor C, et al. Pulsed monoclonal antibody treatment modulates T cell responses in multiples sclerosis but induces autoimmune thyroid disease. Lancet 1999; 354: 1691-5.
10. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339: 285-91.
11. Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, et al. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics 1998; 2: 24-33.
12. Cornelis F, Faure S, Martinez M, Prud'homme JF, Fritz P, Dib C, et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 1998; 95: 10746-50.
13. De Keyser J. Autoimmunity in multiple sclerosis. Neurology 1988; 38: 371-4.
14. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, et al. A full genome search in multiple sclerosis. Nat Genet 1996; 13: 472-6.
15. Ertle AR, London MR. Insights into asthma prevalence in Oregon. J Asthma 1998; 35: 281-9.
16. Fleiss J. Statistical methods for rates and proportions. 2nd ed. New York: Wiley; 1981.
17. Frovig AG, Presthus J, Sponheim N. The significance of allergy in the etiology and pathogenesis of multiple sclerosis. Acta Neurol Scand 1967; 43: 215-27.
18. Gaffney PM, Kearns GM, Shark KB, Ortmann WA, Selby SA, Malmgren ML, et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998; 95: 14875-9.
19. Gatling W, Budd S, Walters D, Mullee MA, Goddard JR, Hill RD. Evidence of an increasing prevalence of diagnosed diabetes mellitus in the Poole area from 1983 to 1996. Diabet Med 1998; 15: 1015-21.
20. Gordon T, Isenberg D. Organ specific and multisystemic autoimmune disease: part of a spectrum which may coexist in the same patient. Clin Rheumatol 1990; 9: 401-3.
21. Hafler DA, Weiner HL. MS: a CNS and systemic autoimmune disease. [Review]. Immunol Today 1989; 10: 104-7.
22. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet 1996; 13: 469-71.
23. Harris T. Projections: a look into the future. In: Church J, editor. Social trends 27: Office for National Statistics. London: Stationery Office; 1997. p. 15-26.
24. Heinzlef O, Alamowitch S, Sazdovitch V, Chillet P, Joutel A, Tournier-Lasserve E, et al. Autoimmune disease in families of French patients with multiple sclerosis. Acta Neurol Scand 1999; 100: 1-5.
25. Heward J, Gough SC. Genetic susceptibility to the development of autoimmune disease [editorial]. [Review]. Clin Sci (Colch) 1997; 93: 479-91.
26. Hochberg MC. Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982. Semin Arthritis Rheum 1990; 19: 294-302.
27. Hopkinson ND, Doherty M, Powell RJ. The prevalence and incidence of systemic lupus erythematosus in Nottingham, UK, 1989-1990. Br J Rheumatol 1993; 32: 110-5.
28. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Arthritis Rheum 1995; 38: 551-8.
29. Kuokkanen S, Geschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ, et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61: 1379-87.
30. Leslie RD, Hawa M. Twin studies in auto-immune disease. [Review]. Acta Genet Med Gemellol (Roma) 1994; 43: 71-81.
31. Matheson J, Pullinger J, editors. Social trends 29: Office for National Statistics. London: Stationery Office; 1999. p. 31.
32. McCombe PA, Chalk JB, Pender MP. Familial occurrence of multiple sclerosis with thyroid disease and systemic lupus erythematosus. J Neurol Sci 1990; 97: 163-71.
33. Midgard R, Gronning M, Ruse T, Kvale G, Nyland H. Multiple sclerosis and chronic inflammatory diseases. A case-control study. Acta Neurol Scand 1996; 93: 322-8.
34. Miller DH, Hornabrook RW, Purdie G. The natural history of multiple sclerosis: a regional study with some longitudinal data. J Neurol Neurosurg Psychiatry 1992; 55: 341-6.
35. Minuk GY, Lewkonia RM. Possible familial association of multiple sclerosis and inflammatory bowel disease [letter]. N Engl J Med 1986; 314: 586.
36. Mitchell PJ, Bebbington M. Myasthenia gravis in pregnancy. Obstet Gynecol 1992; 80: 178-81.
37. Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. [Review]. Rheum Dis Clin North Am 1997; 23: 195-212.
38. Noble JA, Valdes AM, Cook M, Klitz W, Thomson G, Erlich HA. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-48.
39. Oro AS, Guarino TJ, Driver R, Steinman L, Umetsu DT. Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996; 97: 1402-8.
40. Patrick C. Organ-specific autoimmune diseases. Immunol Ser 1993; 42: 1888-93.
41. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
42. Rang EH, Brooke BN, Hermon-Taylor J. Association of ulcerative colitis with multiple sclerosis [letter]. Lancet 1982; 2: 555.
43. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DAS. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996; 119: 449-55.
44. Robertson NP, Deans J, Compston DAS. Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998; 65: 492-6.
45. Rotondi M, Oliviero A, Profice P, Mone CM, Biondi B, Del Buono A, et al. Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. J Endocrinol Invest 1998; 21: 748-52.
46. Sadovnick AD, Paty DW, Yannakoulias G. Concurrence of multiple sclerosis and inflammatory bowel disease [letter]. N Engl J Med 1989; 321: 762-3.
47. Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996; 13: 464-8.
48. Scott E. Prevalence of pernicious anaemia in Great Britain. J Coll Gen Pract 1960; 3: 80-4.
49. Shank JC. A study of thyroid disease in family practice. J Fam Pract 1976; 3: 247-53.
50. Sheehan NJ, Stanton-King K. Polyautoimmunity in a young woman. Br J Rheumatol 1993; 32: 254-6.
51. Spadaro M, Amendolea MA, Mazzucconi MG, Fantozzi R, Di Lello R, Zangari P, et al. Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler 1999; 5: 121-5.
52. Stinissen P, Medaer R, Raus J. Myelin reactive T cells in the autoimmune pathogenesis of multiple sclerosis. [Review]. Mult Scler 1998; 4: 203-11.
53. Tada H, Hidaka Y, Tsuruta E, Kashiwai T, Tamaki H, Iwatani Y, et al. Prevalence of postpartum onset of disease within patients with Graves' disease of child-bearing age. Endocr J 1994; 41: 325-7.
54. Todd JA, Farrall M. Panning for gold: genome-wide scanning for linkage in type 1 diabetes. [Review]. Hum Mol Genet 1996; 5 Spec No: 1443-8.
55. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al.The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7: 481-93.
56. Warren SA, Warren KG. Multiple sclerosis and diabetes mellitus: further evidence of a relationship. Can J Neural Sci 1982; 9: 415-9.
57. Willis AC, Vince FP. The prevalence of Addison's disease in Coventry, UK. Postgrad Med J 1997; 73: 286-8.
58. Wynn DR, Rodriguez M, O'Fallon MM, Kurland LT. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990; 40: 780-6.